MarketCapExport financials
Molina Healthcare (MOH)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
Molina Healthcare Income Statement 2025-2008 | MOH
Brief overview of financial results at Molina Healthcare
The comparison covers a five-year financial horizon. The revenue attributed to Molina Healthcare moved from $19.4 billion to $45.4 billion between the two endpoints. The total change was +133.9%, with a CAGR of approximately 18.5%. Top-line growth remained consistently strong over the period.
The five-year change in gross profit reached +64.8%: from $3.6 billion to $5.9 billion. Direct costs outpaced revenue, limiting the benefit of changes in sales. Gross profit as a share of revenue changed from 18.6% to 13.1%. The contraction points to pressure from direct costs or weaker pricing power.
The operating result measured by EBITDA moved from 1.2 billion dollars to 976 million dollars, or −16.3%. EBITDA lagged revenue, showing weaker operating momentum. The EBITDA share of revenue changed from 6% to 2.1%. A lower EBITDA share weakens the quality of the result.
Net income changed from 673 million dollars to 472 million dollars (−29.9%). The decline reduces the quality of the financial trajectory.
Market value was 12.5 billion dollars at the start and 6.7 billion dollars at the end. The negative valuation trend points to increased investor caution.
Conclusion
The financial trajectory is weak and requires a cautious interpretation. Key strengths include sales growth. The most visible risks are pressure from direct costs, a weaker final result and limited operating profitability. Further direction will depend on top-line growth, operating profitability, and net income.
Annual Income Statement Molina Healthcare
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
6.68 B | 15.7 B | 22.7 B | 17.4 B | 18.4 B | 12.5 B | 7.86 B | 8.31 B | 5.46 B | 3.19 B | 3.07 B | 2.53 B | 1.66 B | 1.32 B | 1.37 B | 746 M | 624 M | - |
Shares |
52.8 M | 57.4 M | 57.7 M | 57.8 M | 57.8 M | 59 M | 62 M | 62 M | 60 M | 57 M | 56 M | 49.7 M | 45.7 M | 46.4 M | 45.8 M | 41.2 M | 38.8 M | - |
Historical Prices |
126 | 274 | 393 | 301 | 318 | 213 | 136 | 116 | 76.7 | 54.3 | 60.1 | 53.5 | 34.8 | 27.1 | 22.3 | 18.1 | 16.1 | 19.4 |
Net Income |
472 M | 1.18 B | 1.09 B | 792 M | 659 M | 673 M | 737 M | 707 M | -512 M | 52 M | 143 M | 62.2 M | 52.9 M | 9.79 M | 20.8 M | 55 M | 30.9 M | - |
Revenue |
45.4 B | 40.6 B | 34.1 B | 32 B | 27.8 B | 19.4 B | 16.7 B | 18.8 B | 19.8 B | 17.7 B | 14.2 B | 9.66 B | 6.58 B | 6.02 B | 4.77 B | 4.09 B | 3.67 B | - |
Cost of Revenue |
39.5 B | 34.4 B | 28.7 B | 27.2 B | 23.7 B | 15.8 B | 13.9 B | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | 2.3 B | 2.5 B | 1.81 B | 1.8 B | 1.62 B | 1.04 B | 868 M | 627 M | 766 M | - | - | - |
Operating Income |
781 M | 1.71 B | 1.57 B | 1.17 B | 1.02 B | 1.08 B | 1.04 B | 1.13 B | -555 M | 306 M | 387 M | 193 M | 137 M | 41.1 M | 136 M | 105 M | 51.9 M | - |
Interest Expense |
- | - | 109 M | 110 M | 120 M | 102 M | 87 M | 115 M | 118 M | 101 M | 66 M | 57 M | 52 M | 16.8 M | 15.5 M | 15.5 M | 13.8 M | - |
EBITDA |
976 M | 1.89 B | 1.74 B | 1.35 B | 1.15 B | 1.17 B | 1.01 B | 1.17 B | 216 M | 407 M | 473 M | 278 M | 202 M | 94 M | 195 M | 166 M | 90 M | - |
Operating Expenses |
- | - | - | - | - | - | 1.38 B | 1.43 B | 1.73 B | 1.53 B | 1.25 B | 858 M | 739 M | 596 M | 621 M | - | - | - |
General and Administrative Expenses |
3.01 B | 2.74 B | 2.46 B | 2.31 B | 2.07 B | 1.48 B | 1.3 B | 1.33 B | 1.59 B | 1.39 B | 1.15 B | 765 M | 666 M | 533 M | 416 M | 346 M | 276 M | - |
All numbers in USD currency
Quarterly Income Statement Molina Healthcare
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
51.1 M | 50.9 M | 51 M | 52.5 M | 53.6 M | 54.6 M | 56 M | 57.6 M | 58.1 M | 57.9 M | 58 M | 57.8 M | 57.7 M | 57.5 M | 58 M | 57.6 M | 57.8 M | 58 M | 58 M | 57.8 M | 57.7 M | 57.7 M | 59 M | 58.7 M | 58.6 M | 60.2 M | 62 M | 62.2 M | 62.1 M | 62.1 M | 62 M | 61.3 M | 61.2 M | 59.8 M | 60 M | 56.5 M | 56 M | 56 M | 57 M | 56 M | 55 M | 55 M | 56 M | 55 M | 50 M | 49 M | 50 M | 47 M | 46.3 M | 46 M | 45.9 M | 45.7 M | 45.4 M | 46 M | 46.8 M | 46.5 M | 46.4 M | 46 M | 45.8 M | 45.8 M | 45.9 M | 45.6 M |
Net Income |
60 M | 14 M | - | 79 M | 255 M | 298 M | - | 326 M | 301 M | 301 M | - | 245 M | 309 M | 321 M | - | 230 M | 248 M | 258 M | - | 143 M | 185 M | 228 M | - | 185 M | 276 M | 178 M | 168 M | 175 M | 196 M | 198 M | 201 M | 197 M | 202 M | 107 M | -262 M | -97 M | -230 M | 77 M | -47 M | 42 M | 33 M | 24 M | 30 M | 46 M | 39 M | 28 M | 34 M | 16 M | 8 M | 4 M | -9.13 M | 7.57 M | 24.6 M | 29.9 M | 25.6 M | 3.36 M | -37.3 M | 18.1 M | -33 M | 19 M | 17.4 M | 17.4 M |
Revenue |
10.9 B | 10.8 B | - | 11.5 B | 11.4 B | 11.1 B | - | 10.3 B | 9.88 B | 9.93 B | - | 8.55 B | 8.33 B | 8.15 B | - | 7.93 B | 8.05 B | 7.77 B | - | 7.04 B | 6.8 B | 6.52 B | - | 5.02 B | 4.62 B | 4.55 B | 4.27 B | 4.24 B | 4.19 B | 4.12 B | 4.66 B | 4.7 B | 4.88 B | 4.65 B | 4.95 B | 5.03 B | 5 B | 4.9 B | 4.53 B | 4.55 B | 4.36 B | 4.34 B | - | 3.61 B | 3.52 B | 3.17 B | - | 2.48 B | 2.31 B | 2.07 B | - | 1.69 B | 1.61 B | 1.59 B | - | 1.54 B | 1.48 B | 1.37 B | - | 1.18 B | 1.17 B | 1.12 B |
Cost of Revenue |
9.44 B | 9.27 B | - | 10 B | 9.83 B | 9.48 B | - | 8.64 B | 8.37 B | 8.41 B | - | 7.31 B | 7.04 B | 6.87 B | - | 6.75 B | 6.87 B | 6.56 B | - | 6.05 B | 5.82 B | 5.47 B | - | 4.1 B | 3.6 B | 3.72 B | - | 3.52 B | 3.47 B | 3.37 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 578 M | 561 M | 583 M | 581 M | 664 M | 566 M | 673 M | 615 M | 446 M | 564 M | 254 M | 546 M | 354 M | 457 M | 454 M | 420 M | - | 374 M | 389 M | 351 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
145 M | 83 M | - | 137 M | 373 M | 433 M | - | 467 M | 434 M | 426 M | - | 359 M | 443 M | 455 M | - | 335 M | 361 M | 372 M | - | 221 M | 273 M | 335 M | - | 289 M | 424 M | 274 M | - | 257 M | 265 M | 280 M | - | 295 M | 342 M | 222 M | - | -81 M | -287 M | 82 M | -6 M | 118 M | 105 M | 89 M | 76 M | 113 M | 116 M | 82 M | 97 M | 40 M | 32 M | 24 M | - | 24.9 M | 46.4 M | 67.9 M | 54.1 M | 2.37 M | -49.4 M | 33.4 M | -16.1 M | 33.6 M | 31.4 M | 31.3 M |
Interest Expense |
- | - | - | - | - | - | - | - | - | 27 M | - | 27 M | 27 M | 28 M | - | 28 M | 27 M | 28 M | - | 30 M | 30 M | 30 M | - | 27 M | 24 M | 21 M | - | 22 M | 22 M | 23 M | - | 26 M | 32 M | 33 M | - | 32 M | 27 M | 26 M | - | 26 M | 25 M | 25 M | - | 15 M | 15 M | 15 M | - | 14.4 M | 14 M | 13.8 M | - | 13.5 M | 11.7 M | 13 M | - | 4.32 M | 3.81 M | 4.3 M | - | 4.38 M | 3.68 M | 3.6 M |
EBITDA |
224 M | 122 M | - | 182 M | 431 M | 481 M | - | 514 M | 480 M | 471 M | - | 401 M | 485 M | 499 M | - | 380 M | 405 M | 412 M | - | 317 M | 304 M | 368 M | - | 353 M | 465 M | 294 M | - | 325 M | 312 M | 305 M | - | 399 M | 415 M | 259 M | - | 58 M | -191 M | 131 M | -6 M | 253 M | 194 M | 133 M | 76 M | 206 M | 178 M | 115 M | 97 M | 139 M | 97.7 M | 57 M | - | 49.1 M | 68.6 M | 89.7 M | 54.1 M | 22.6 M | -29.8 M | 51.8 M | -16.1 M | 51.4 M | 47.9 M | 49.4 M |
General and Administrative Expenses |
724 M | 779 M | - | 729 M | 711 M | 774 M | - | 676 M | 691 M | 711 M | - | 608 M | 618 M | 591 M | - | 560 M | 551 M | 571 M | - | 532 M | 484 M | 473 M | - | 368 M | 345 M | 317 M | - | 323 M | 328 M | 302 M | - | 311 M | 335 M | 352 M | - | 383 M | 405 M | 439 M | - | 343 M | 351 M | 340 M | - | 287 M | 287 M | 256 M | - | 179 M | 193 M | 188 M | - | 176 M | 161 M | 141 M | - | 127 M | 126 M | 121 M | - | 99.6 M | 96.9 M | 94.4 M |
All numbers in USD currency
The income statement is one of the three key financial reports of a company Molina Healthcare (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:
- How much revenue the company earned
- How much it spent on production, personnel, marketing, taxes, etc.
- What profit remained in the end
Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.
Features- The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
- Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
- A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.
Reports on the profits and losses of other stocks in the Health care industry
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
Cigna Corporation
CI
|
$ 290.11 | 3.33 % | $ 76.4 B |  USA |
 |
Centene Corporation
CNC
|
$ 69.46 | 4.58 % | $ 34.3 B | USA |
 |
CVS Health Corporation
CVS
|
$ 95.91 | 1.32 % | $ 122 B | USA |
 |
Humana
HUM
|
$ 411.5 | 0.41 % | $ 49.6 B | USA |
 |
NovoCure Limited
NVCR
|
$ 16.03 | 3.34 % | $ 1.79 B |  Jersey |
 |
UnitedHealth Group Inc.
UNH
|
$ 384.81 | 2.13 % | $ 349 B | USA |
 |
Triple-S Management Corporation
GTS
|
- | 0.28 % | $ 847 M | USA |
 |
Magellan Health, Inc.
MGLN
|
- | -0.19 % | $ 2.49 B | USA |
 |
Anthem
ANTM
|
- | -2.32 % | $ 107 B | USA |